Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice

Stem Cells

Volumn 27, Issue 9, 2009, Pages 2342-2352

  Lucas, Trevor ^a   Abraham, Dietmar ^a   Untergasser, Gerold ^b   Zins, Karin ^a   Hofer, Erhard ^a   Gunsilius, Eberhard ^b   Aharinejad, Seyedhossein ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adenovirus; Cellular therapy; Endothelial cell; Gene delivery systems in vivo or in vitro; Immunodeficient mouse; Peripheral blood stem cells; Progenitor cells; Xenogeneic stem cell transplantation

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR CD115; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CELL EXPANSION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MACROPHAGE; PROSTATE CANCER; PROTEIN SECRETION; STEM CELL; TUMOR GROWTH; TUMOR XENOGRAFT; XENOTRANSPLANTATION;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; STEM CELL TRANSPLANTATION; TISSUE THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; MUS;

EID: 70349972369     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.145     Document Type: Article

References (44)

1. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001;86:23-33. (Pubitemid 32663933)
2. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
3. Lucas T, Abraham D, Aharinejad S. Modulation of tumor associated macrophages in solid tumors. Front Biosci 2008;13:5580-5588.
4. Venneri MA, De Palma M, Ponzoni M et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007;109:5276-5285. (Pubitemid 46890548)
5. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-2234. (Pubitemid 39331817)
6. Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-266. (Pubitemid 43121975)
7. Lin EY, Nguyen AV, Russell RG et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-740.
8. Leek RD, Lewis CE, Whitehouse R et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-4629. (Pubitemid 26338061)
9. Lissbrant IF, Stattin P, Wikstrom P et al. Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 2000;17:445-451.
10. Paulus P, Stanley ER, Schafer R et al. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res 2006;66:4349-4356.
11. Aharinejad S, Paulus P, Sioud M et al. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 2004;64:5378-5384. (Pubitemid 39006559)
12. Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leuk Res 2007;31:439-444.
13. Untergasser G, Koeck R, Wolf D et al. CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application. Exp Gerontol 2006;41:600-608. (Pubitemid 43867226)
14. Purhonen S, Palm J, Rossi D et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008;105:6620-6625. (Pubitemid 351754556)
15. Li B, Sharpe EE, Maupin AB et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006;20:1495-1497. (Pubitemid 44961985)
16. Moore XL, Lu J, Sun L et al. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 2004;11:811-818.
17. Wang H, Thompson TC. Gene-modified bone marrow cell therapy for prostate cancer. Gene Ther 2008;15:787-796. (Pubitemid 351627363)
18. Beerepoot LV, Mehra N, Vermaat JS et al. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004;15:139-145. (Pubitemid 38139616)
19. Davidoff AM, Ng CY, Brown P et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001;7:2870-2879. (Pubitemid 32911397)
20. Stanley ER. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol 1985;116:564-587.
21. ten Hagen TL, van Vianen W, Bakker-Woudenberg IA. Isolation and characterization of murine Kupffer cells and splenic macrophages. J Immunol Methods 1996;193:81-91.
22. Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809. (Pubitemid 46348173)
23. Mead LE, Prater D, Yoder MC et al. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol 2008;Chapter 2:Unit 2C 1.
24. Vajkoczy P, Blum S, Lamparter M et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003;197:1755-1765. (Pubitemid 36745350)
25. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004;14:628-638.
26. Wang ZE, Myles GM, Brandt CS et al. Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain. Mol Cell Biol 1993;13:5348-5359. (Pubitemid 23260638)
27. Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 2006;13:175-181. (Pubitemid 43755858)
28. Nolan DJ, Ciarrocchi A, Mellick AS et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007;21:1546-1558. (Pubitemid 46955726)
29. Gao D, Nolan DJ, Mellick AS et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-198.
30. Peters BA, Diaz LA, Polyak K et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-262. (Pubitemid 40460552)
31. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712. (Pubitemid 36749219)
32. Oh HK, Ha JM, O E, et al. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Cancer Res 2007;67:4851-4859. (Pubitemid 46915312)
33. Bagley RG, Weber W, Rouleau C et al. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res 2005;65:9741-9750. (Pubitemid 41541451)
34. Debatin KM, Wei J, Beltinger C. Endothelial progenitor cells for cancer gene therapy. Gene Ther 2008;15:780-786. (Pubitemid 351627362)
35. Wei J, Blum S, Unger M et al. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 2004;5:477-488. (Pubitemid 38610249)
36. Sica A, Rubino L, Mancino A et al. Targeting tumour-associated macrophages. Expert Opin Ther Targets 2007;11:1219-1229.
37. Luo Y, Zhou H, Krueger J et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006;116:2132-2141. (Pubitemid 44162322)
38. Robinson SC, Scott KA, Wilson JL et al. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 2003;63:8360-8365. (Pubitemid 37549490)
39. Hagemann T, Lawrence T, McNeish I et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008;205:1261-1268.
40. Ide H, Hatake K, Terado Y et al. Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis. Hum Cell 2008;21:1-6.
41. Stanley.CSF-1. In: Oppenheim J, Feldmann M, eds. Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defence. London: Academic Press, 2000:911-934.
42. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: Implications for therapy. Trends Mol Med 2009;15:180-189.
43. Wang XX, Zhang FR, Shang YP et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial. J Am Coll Cardiol 2007;49:1566-1571.
44. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008;18:33-37.